Institute of Liver Studies, King's College London School of Medicine at King's College Hospital, Denmark Hill Campus, London, UK.
Dis Markers. 2010;29(6):301-11. doi: 10.3233/DMA-2010-0745.
Among various infectious agents possibly involved in the pathogenesis of primary biliary cirrhosis (PBC), Escherichia Coli (E. coli) has received special attention because of epidemiological and experimental evidence linking this bacterium with the disease's development. This review discusses early and more recent epidemiological studies associating recurrent urinary tract infections with E. coli and the development of PBC. We also critically review data provided over the years demonstrating disease-specific humoral and cellular immune responses against E. coli antigens in patients with PBC. Finally, we assess the relevance of experimental findings reporting cross-reactive immunity between mimicking sequences of E. coli and the major PBC mitochondrial antigens in the pathogenesis of the PBC. We also address the extent to which molecular mimicry and immunological cross-reactivity can be considered as a critical pathogenic process linking infection with self destruction.
在可能参与原发性胆汁性肝硬化 (PBC) 发病机制的各种感染因子中,由于有流行病学和实验证据将这种细菌与疾病的发展联系起来,大肠杆菌 (E. coli) 受到了特别关注。本文综述了早期和最近的流行病学研究,这些研究将复发性尿路感染与大肠杆菌和 PBC 的发展联系起来。我们还批判性地回顾了多年来提供的资料,这些资料表明 PBC 患者对大肠杆菌抗原存在疾病特异性体液和细胞免疫反应。最后,我们评估了报告大肠杆菌模拟序列与 PBC 主要线粒体抗原之间交叉反应性免疫的实验结果在 PBC 发病机制中的相关性。我们还探讨了分子模拟和免疫交叉反应在多大程度上可以被认为是将感染与自身破坏联系起来的关键致病过程。